Fildena® - a new regulator of potency based on Sildenafil, a distinctive feature of which is bold design in purple color. If the manufacturers of other generics create their own medicines in the colors of Viagra® to make it as similar as possible to the basic prototype, for example, Fortune Health Care, the producers of Fildena® 100 mg, on the contrary, want to show all the individuality of the drug. And this individuality deserves your attention. Psychologists say that purple color increases your self-esteem. Fortune Health Care contributed to this increase by creating the most popular dosage of the drug in purple color. The Studies of Fildena® 100 mg in Europe showed that this drug contains a very high-quality Sildenafil, which has no difference in effectiveness from the famous Viagra®. In addition, the coat of all Fildena® dosages is made of a special substance that accelerates the digestibility of the tablet, giving an average effect of 5% faster.

Tadalista® is a powerful and economical alternative to Cialis®. As a matter of fact, these two medications differ only by the manufacturer, the actions and the effects remain the same, as the basis of a medicine is still tadalafil. Cialis® is simply a trademark in Western countries. Tadalista® is produced by the pharmacological concern Fortune Health Care. The absence of a huge amount of expenses for advertising promotion allowed the Indian manufacturer to offer an effective medicine at a low price.

Vardenafil was first released in 2003 under the brand name Levitra® designed by Bayer. Since that time, the medicine quickly gained popularity among men and even became a favorite medical agent of many "professional users" - adult movie actors. Why should we recommend to buy an Indian brand made by Centurion Laboratories, Vilitra®, but not Levitra®? The answer is simple - Levitra® has a sky-high price, which far exceeds the median budget of the average European man. And Vilitra® does not differ from its counterpart either in composition or in effect, but the price is up to 15 times smaller. What these drugs have in common are good therapeutic properties, a high level of safety and a mild effect.